Longitudinal Analysis of Long-Term Safety and Efficacy of Recombinant Factor VIII Fc Fusion Protein (rFVIIFc) in Adults/Adolescents with Severe Hemophilia a

Barbara Konkle,K John Pasi,David J Perry,Johnny Mahlangu,Savita Rangarajan,Simon A Brown,Hideji Hanabusa,Ingrid Pabinger,Lynda M Cristiano,Elisa Tsao,Bent Winding,Desilu Glazebrook,Stefan Lethagen,Shannon Jackson

doi:10.1182/blood.v128.22.1413.1413

Longitudinal Analysis of Long-Term Safety and Efficacy of Recombinant Factor VIII Fc Fusion Protein (rFVIIFc) in Adults/Adolescents with Severe Hemophilia a

Barbara Konkle, K John Pasi + Show 12 more

Open Access

https://doi.org/10.1182/blood.v128.22.1413.1413

Copy DOI

Journal: Blood

Publication Date: Dec 2, 2016

Affiliation: Bloodworks Northwest, Addenbrooke's Hospital, University of the Witwatersrand, Basingstoke and North Hampshire Hospital, Queensland Children’s Hospital, Ogikubo Hospital, Medical University of Vienna, Biogen (United States), Swedish Orphan Biovitrum (Sweden), St. Paul's Hospital

#Research Funding #Efficacy Of rFVIIIFc + Show 8 more

Abstract
Full-Text
Similar Papers

Abstract

Longitudinal Analysis of Long-Term Safety and Efficacy of Recombinant Factor VIII Fc Fusion Protein (rFVIIFc) in Adults/Adolescents with Severe Hemophilia a

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title

Journal

Date

Author

View more papers

More From: Blood

Paper Title

Journal

Date

Author

View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.